Autoreactive CD4 T cells in healthy mice
Autoreactive CD4 T cells in healthy mice
批准号:
10170262
负责人:
LESZEK IGNATOWICZ
金额:
$38.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-06-01 至 2025-05-31
关键词:
AblationAgonistAntigen ReceptorsAntigen-Presenting CellsAutoantigensAutoimmune DiseasesAutoimmunityBar CodesBypassCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCellsChromatinDevelopmentDevicesDiphtheria ToxinDisabled PersonsEpigenetic ProcessGene TargetingGenomicsHomeostasisHumanImmune responseIndividualInfectionLeadMHC Class I GenesMHC Class II GenesMaintenanceMalignant NeoplasmsMicrofluidicsModelingMusOrganPathogenicityPeptidesPeripheralProtocols documentationReceptor CellRegulatory T-LymphocyteResearchRestRoleSelf ToleranceSpecificityStromal CellsSystemT-LymphocyteT-Lymphocyte SubsetsTCR ActivationTestingTherapeuticThymus GlandTissuesTransposaseautoreactive T cellautoreactivitycentral tolerancehigh throughput analysislymphoid organnovel therapeuticsperipheral tolerancepreventreconstructionresponsesingle-cell RNA sequencingthymocytetranscriptome
中文摘要
在胸腺中,中枢耐受应该消除大多数未成熟的T细胞,
表达自身反应性致病抗原受体(αβTCR)。然而,数量不详的
自身反应细胞逃脱缺失或致力于免疫抑制,调节性连接(Tregs)。
Treg控制外周耐受,维持潜在自身反应性T细胞的休眠。
然而,患有残废Tregs的小鼠和人类迅速发展为多器官自身免疫并死亡。
年轻,表现出几乎所有CD4+克隆的多克隆激活。因此,我们假设
嵌入在外围曲目中的自动反应克隆的数量可能要高得多(即
所有CD4+细胞的三分之一以上),而不是目前预期的水平。在具体目标1中,
我们将研究不同自体肽在胸腺内的表达是如何支持或阻止
自身反应性T细胞逃避中枢耐受。此方法将潜在地记录
自身反应性的CD4+克隆通常作为静止细胞侵入B6小鼠的淋巴器官。
接下来,我们将测试这些细胞对一组已知的自然呈现的自体多肽的体外反应。
通过小鼠抗体分子来确定这些克隆是由无处不在的还是特定的
自身抗原。在特定目标2中,我们将调查为什么表达单一自身抗原的小鼠
全身自体免疫的主要表现在特定的器官和检查作用
在这个模型中非经典的CD4+T细胞在自身免疫中的作用。在目标3中,我们将使用一个新的单细胞
来自10X基因组公司的RNA序列系统,用于检测单个CD4+细胞的转录
和本地αβTCR以识别潜在自身反应细胞中Treg靶向的基因以保持
它们处于休眠状态,并阻止自身免疫。总的来说,此应用程序将重新访问相对的
多种耐受机制在维持自我稳态中的重要性
并可以揭示Treg如何控制自身反应性的新机制。
英文摘要
In the thymus, central tolerance should eliminate the majority of immature T cells that
express autoreactive, pathogenic antigen receptors (αβTCRs). However, an unknown number of
autoreactive cells escape deletion or commit to immunosuppressive, regulatory linage (Tregs).
Tregs control peripheral tolerance and sustain dormancy of potentially autoreactive T cells.
However, mice and humans with disabled Tregs rapidly develop multiorgan autoimmunity and die
young, manifesting polyclonal activation of almost all CD4+ clones. Thus, we hypothesized that
the number of autoreactive clones embedded in the peripheral repertoire can be much higher (i.e.
over one-third of all CD4+ cells) as compared to what is currently anticipated. In Specific Aim 1,
we will examine how the intrathymic expression of different self-peptides supports or prevents an
escape of autoreactive T cells from central tolerance. This approach will document that potentially
self-reactive CD4+ clones commonly trespass to lymphoid organs of B6 mice as quiescent cells.
Next, we will test these cells ex vivo responses to a known set of self-peptides naturally presented
by mouse Ab molecules to determine if these clones are triggered by ubiquitous or specific
autoantigens. In Specific Aim 2, we will investigate why mice expressing single autoantigen
across the body have main autoimmunity manifestation in specific organs and examine the role
of non-classical CD4+ T cells in autoimmunity in this model. In Aim 3 we will use a new single-cell
RNA seq system from 10X Genomics, to examine in individual CD4+ cells their transcriptomes
and native αβTCRs to identify genes targeted by Tregs in potentially autoreactive cells to keep
them dormant and prevent autoimmunity. Overall, this application will revisit the relative
importance of various mechanisms of tolerance in the maintenance of homeostasis to self-
antigens and can reveal new mechanisms of how Tregs control self-reactivity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microbiome and immunosenescence of T cells repertoire
-
批准号:10661505
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2020
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
Autoreactive CD4 T cells in healthy mice
-
批准号:10621383
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2020
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
Microbiome and immunosenescence of T cells repertoire
-
批准号:10417234
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2020
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
Microbiome and immunosenescence of T cells repertoire
-
批准号:10259681
-
项目类别:
-
资助金额:$38.98万
-
财政年份:2020
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
Autoreactive CD4 T cells in healthy mice
-
批准号:10404633
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2020
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
Diversity of intraepithelial CD8aa T cells that recognize antignes from commensal flora
-
批准号:9413085
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2017
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
Antigenic specificities of intestinal CD4+Foxp3+ T cells.
-
批准号:9006761
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2015
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
Role of CD4+T cells in maintenance of intestinal homeostasis
-
批准号:8819131
-
项目类别:
-
资助金额:$33.01万
-
财政年份:2014
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
Role of CD4+T cells in maintenance of intestinal homeostasis
-
批准号:9464232
-
项目类别:
-
资助金额:$32.95万
-
财政年份:2014
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
Role of CD4+T cells in maintenance of intestinal homeostasis
-
批准号:8697992
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2014
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
Antigenic specificities of intestinal CD4+Foxp3+ T cells.
-
批准号:8894949
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2014
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
Ontogeny of natural regulatory T cells.
-
批准号:7735488
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2009
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
Ontogeny of natural regulatory T cells.
-
批准号:7897828
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2009
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
Visualization of individual Foxp3+ T cells during an onset and progression of aut
-
批准号:7888322
-
项目类别:
-
资助金额:$36.38万
-
财政年份:2008
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
Visualization of individual Foxp3+ T cells during an onset and progression of aut
-
批准号:7646288
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2008
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
Visualization of individual Foxp3+ T cells during an onset and progression of aut
-
批准号:8076741
-
项目类别:
-
资助金额:$36.02万
-
财政年份:2008
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
Visualization of individual Foxp3+ T cells during an onset and progression of aut
-
批准号:7508212
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2008
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
Visualization of individual Foxp3+ T cells during an onset and progression of aut
-
批准号:8274807
-
项目类别:
-
资助金额:$36.02万
-
财政年份:2008
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
Antigen biased positive selection of CD4+ T cells
-
批准号:6640229
-
项目类别:
-
资助金额:$25.75万
-
财政年份:1997
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
ANTIGEN BIASED POSITIVE SELECTION NEONATAL CD4+ T CELLS
-
批准号:2889486
-
项目类别:
-
资助金额:$13.3万
-
财政年份:1997
-
负责人:LESZEK IGNATOWICZ
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: